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Background: Signaling through the TCR is crucial for the generation of different cellular responses including
proliferation, differentiation, and apoptosis. A growing body of evidence indicates that differences in the magnitude
and the duration of the signal are critical determinants in eliciting cellular responses.
Results: Here, we have analyzed signaling dynamics correlating with either unresponsiveness or proliferation
induced upon TCR/CD28 ligation in primary human T cells. We used two widely employed methods to stimulate T
cells in vitro, antibodies either cross-linked in solution (sAbs) or immobilized on microbeads (iAbs). A comparative
analysis of the signaling properties of iAbs and sAbs revealed that, under proliferation-inducing conditions,
feedback regulation is markedly different from that leading to an unresponsive state. In fact, upon iAbs stimulation
TCR-mediated signaling is prolonged by a positive feedback loop involving Erk, whereas sAbs strongly activate
inhibitory molecules that likely terminate signaling. We additionally found that, by enhancing the phosphorylation
of Src family kinases under proliferation-inducing conditions, signaling and T-cell activation are terminated.
Conclusions: In summary, our analysis documents TCR signaling kinetics and feedback regulation under conditions
of stimulation inducing either unresponsiveness or proliferation.
Keywords: TCR-mediated signaling, Feedback regulation, Cell-fate specification, T-cell activation, Lck, Erk, Signaling
dynamics, CD4 crosslinkingBackground
Ligation of the T cell receptor (TCR) triggers intracellular
signals which may result in the initiation of markedly dif-
ferent cellular programs leading to differentiation, activa-
tion, survival, or apoptosis of T cells. One of the major
questions in cell biology is how the activation of the same
canonical signaling cascades dictates distinct biological
outcomes. How signals are interpreted and translated into
specific cellular outcomes has been extensively studied in
PC-12 cells [1,2]. In these cells, it appears that differences
in the magnitude and the duration of the Erk signal are
critical determinants in eliciting the cellular response. For
example, sustained Erk activation upon NGF treatment
causes differentiation of the PC-12 cell line, whereas tran-
sient Erk activation upon EGF stimulation induces prolif-
eration in the same cells [3]. Further studies have shown* Correspondence: luca.simeoni@med.ovgu.de
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reproduction in any medium, provided the orthat NGF and EGF elicit different feedback regulation of
the Ras-Erk cascade, which in turn results in distinct
temporal profiles of Erk activity [4]. Whereas EGF triggers
a negative feedback shutting off Raf-1 activity, NGF stimu-
lation induces a positive feedback regulation of Raf-1.
Differences in the duration of Erk activity are sensed by
downstream transcription factors, thus altering the expres-
sion of specific genes required to carry out the cellular
responses [5].
A similar dynamic behavior of Erk activity seems to exist
also in thymocytes where strong and transient Erk activa-
tion induces apoptosis, whereas moderate but sustained
Erk activity induces differentiation of immature T cells [6]
and CD8+ TCR transgenic T cells [7]. How the dynamics of
Erk activation is regulated in mature T cells is not yet clear.
Here, we have used primary human T cells to analyze
TCR activation kinetics and feedback regulation. T cells
were stimulated with CD3 and CD28 antibodies either
cross-linked in solution (sAbs) or immobilized on microbe-
ads (iAbs), which are two commonly used methods to studyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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transient signal and an abortive T-cell response resulting in
unresponsiveness, whereas stimulation with iAbs induces
sustained activation of the Erk cascade and cell proliferation
[8]. We provide evidence that feedback regulation under
proliferation-inducing conditions is markedly different
from that leading to unresponsiveness. We demonstrate
that sAbs activate negative feedback loops that terminate
TCR-mediated signaling, whereas stimulation with iAbs
results in the establishment of a positive feedback loop in-
volving Erk-mediated phosphorylation of Lck prolonging
TCR-mediated signaling. Collectively, our analysis pro-
vides novel insights into the regulation of the dynamic be-
havior of the TCR signaling module that controls cell-fate
specification in primary human T cells.
Results
Sustained TCR-mediated signaling correlates with
proliferation, whereas transient signaling parallels with
unresponsiveness
Peripheral human T cells were stimulated using sAbs or
iAbs. These stimuli induce markedly different activationFigure 1 Analysis of the signaling signature and functional effects of
with either soluble (sAbs) or immobilized (iAbs) CD3xCD28 mAbs for the in
immunoprecipitates C) were prepared and analyzed by Western blotting u
independent experiments is shown. The phosphorylation of TCRζ was quan
normalized to the corresponding total TCRζ signal. Data represent the mea
independent experiments. E) T cells were labeled with CFSE and stimulated
content on a FACS Calibur. One representative experiment of three indepekinetics and cellular responses (Figure 1). Stimulation
with sAbs resulted in a strong and transient induction of
global tyrosine phosphorylation, as well as of ZAP70,
LAT, and PLCγ-1. In contrast, when primary human
T cells were treated with iAbs, global tyrosine phosphor-
ylation and the phosphorylation of ZAP70, LAT and
PLCγ-1 were weak, but sustained (Figure 1A, B). Add-
itionally, phosphorylation of TCRζ was greatly and rap-
idly enhanced upon sAbs. In contrast, iAbs stimulation
induces only weak TCRζ phosphorylation (Figure 1C).
Interestingly, the phosphorylation kinetics of PAG/Cbp,
a transmembrane adaptor protein running at about
70 KDa which is dephosphorylated upon TCR stimula-
tion [9], is comparable under both stimulation condi-
tions (Figure 1A). We next analyzed the signaling
kinetics of the Erk cascade. Surprisingly, we found that
Erk was very strongly activated under both conditions of
stimulation. However, the activation induced by iAbs was
sustained and lasted up to 90 minutes whereas, upon
stimulation with sAbs Erk activation was transient, peaked
at 1–5 minutes, and rapidly declined thereafter (Figure 1D).
Thus, despite the weak activation of proximal signalingsAbs and iAbs stimulation. A-D) Purified human T cells were treated
dicated time periods. Total cell lysates (A, B, and D) or TCRζ
sing the indicated Abs. One representative immunoblot of at least 3
tified using the 1D ImageQuant software and the values were
n of the phosphorylation levels shown as arbitrary units ± SEM of 3
as indicated. Proliferation was assessed after 72h by analyzing CFSE
ndent experiments is shown.
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longed activation of downstream signaling pathways.
It is generally accepted that transient signals triggered
by soluble antibodies cannot induce productive T-cell
responses. Indeed, we and others have demonstrated that
human peripheral T cells, mouse OT-I transgenic T cells,
and cytotoxic T-lymphocyte clones are not activated and
do not differentiate upon stimulation with antibodies
cross-linked in suspension [7,8,10]. Here, we have stimu-
lated primary human T cells with either sAbs or iAbs and
analyzed their functional responses. Treatment with sAbs
failed to induce T-cell proliferation (Figure 1E). Con-
versely, Figure 1E shows that treatment of T cells with
iAbs led to a strong proliferative response.Transient signaling is regulated via negative regulatory
feedbacks
The data presented above, show that sAbs induced a rapid,
but transient TCR-mediated signaling kinetics, which can-
not induce productive T-cell response, whereas stimulation
with iAbs resulted in a sustained activation of a variety of
signaling molecules and led to proliferation. These data in-
dicate that there may be different regulatory mechanisms
induced upon sAbs vs. iAbs stimulation. Thus, we next
investigated how TCR-mediated signaling is differentially
regulated under the two conditions. We hypothesized that
a fast internalization of the available TCR molecules upon
stimulation with sAbs could provide an explanation for
the rapid termination of TCR-mediated signaling. There-
fore, we compared the expression levels of the TCR after
stimulation with either sAbs or iAbs by flow cytometry.
Figure 2A shows that sAbs induce a slow rate of TCR
downregulation, which became evident after 30 minutes of
stimulation. It is important to note that the majority of the
signaling molecules that we have tested reverted to the
dephosphorylated/inactive state already 15 minutes after
sAbs stimulation (Figure 1). Therefore, termination of
TCR-mediated signaling occurs before TCR internaliza-
tion. On the other hand, the data presented in Figure 2A
show that stimulation with iAbs does not reduce, but ra-
ther slightly increases TCR levels. This is likely due to the
fact that Abs bound to a solid matrix limit TCR internal-
ization, but do not interfere with its transport to the
plasma membrane. Moreover, we have previously shown
that sustained TCR-mediated signaling and proliferation
can occur under conditions of stimulation inducing TCR
downregulation [7]. Thus, on the basis of these observa-
tions, we exclude that TCR internalization induced by
sAbs is the cause of transient signaling.
Having ruled out this possibility, we next focused on the
analysis of feedback regulation events, which have been
shown to play a crucial role in T-cell activation [11-13].
Proximal negative feedback loops can be activated by theTCR signalosome and can regulate the amplitude, the dur-
ation, and the specificity of the signal (reviewed in Acuto
et al. [13]). We asked the question of whether the stimula-
tion with sAbs induced the activation of negative regula-
tory molecules that may terminate signaling, thus resulting
in the transient signal observed above. Among the many
inhibitory molecules organizing negative regulatory cir-
cuits, we decided to focus on c-Cbl, an E3 ubiquitin ligase
belonging to the CBL family, and the adaptor protein
Dok2, which regulate TCR-mediated signaling through
two different mechanisms. Whereas members of the CBL
family are involved in the downregulation of signaling
molecules via ubiquitination [14], Dok2 and its homolog
Dok1 inhibit the activation of signaling pathways by com-
peting for binding to SH2 domains or by recruiting other
negative regulators, such as SHIP1 and RasGAP, to the
TCR signalosome [15]. The activity of both c-Cbl and
Dok2 have been reported to be regulated by tyrosine phos-
phorylation [15-17] and can be easily monitored by using
anti-c-Cbl and anti-Dok2 phosphospecific antibodies, re-
spectively. Figure 2B shows that upon sAbs stimulation, T
cells very rapidly and strongly phosphorylated both c-Cbl
and Dok2, whereas, treatment of human T cells with iAbs
resulted only in a very weak phosphorylation of both
molecules.
c-Cbl targets many signaling molecules for degradation,
including ZAP70 [18]. Thus, we next tested whether sAbs,
in addition to inducing strong c-Cbl phosphorylation,
would also induce ZAP70 ubiquitination and degradation.
We have previously shown in mouse OT-I T cells that ubi-
quitination of ZAP70 results in the appearance of ZAP70
bands displaying retarded migration in SDS-PAGE [7].
We checked whether stimulation with soluble CD3xCD28
Abs also resulted in the appearance of ZAP70 bands
running at a higher molecular weight in primary human
T cells and we found that activation/phosphorylation of
c-Cbl upon stimulation with sAbs indeed correlates with
retarded ZAP70 migration (Figure 2C). Additionally, the
data presented in Figure 2C suggest that stimulation with
sAbs also induced ZAP70 degradation. Conversely, stimu-
lation with iAbs did not significantly induce either c-Cbl
phosphorylation or retarded migration and degradation of
ZAP70 (Figure 2C). Thus, it appears that stimulation with
sAbs activates inhibitory feedback loops that may be re-
sponsible for terminating TCR-mediated signaling.
In addition to inducing a strong tyrosine phosphoryl-
ation of c-Cbl and Dok2, stimulation with sAbs also
results in a strong phosphorylation of TCR proximal sig-
naling molecules including TCRζ, ZAP70, and LAT
(Figure 1B, 1C). Therefore, we investigated whether sAbs
induce a stronger activation of the tyrosine kinases Lck
and Fyn compared to iAbs. We immunoprecipitated TCRζ
and assessed the level of active Lck and Fyn associated
with the TCR. As shown in Figure 2D, sAbs stimulation
Figure 2 sAbs, but not iAbs, induce inhibitory feedback loops. Purified human T cells were treated with either soluble (sAbs) or immobilized
(iAbs) CD3xCD28 mAbs for the indicated time points. A) Measurement of TCR internalization. The expression of the TCR was assessed by
PE-conjugated anti-TCRαβ mAb staining analysis by flow cytometry. Data represent the % of the mean fluorescence intensity (MFI) of the TCR
expression relative to time 0 of 4 independent experiments. B) The phosphorylation of c-Cbl on Y731 and Dok2 on Y351 was determined by
Western blotting. The phosphorylated c-Cbl and Dok2 bands were quantified using the 1D ImageQuant software and the values were normalized
to the corresponding β-actin signal. Data represent the mean of the phosphorylation levels shown as arbitrary units ± SEM of at least 4
independent experiments. C) The expression of ZAP70 was determined by Western blotting. Equal loading is shown by reprobing immunoblots
with antibodies specific for β-actin. ZAP70 bands were quantified as above. Data represent the mean of the expression levels shown as arbitrary
units ± SEM of 6 independent experiments. D) Tyrosine phosphorylation of Fyn and Lck in the activation loop was determined by Western
blotting using the pSrc (Y416) antibody. Bands were quantified using the 1D ImageQuant software and values were normalized to the
corresponding total Fyn and Lck signals. Data on the graph represent the mean of the phosphorylation levels shown as arbitrary units ± SEM of 4
independent experiments. Asterisks (*) indicate the Ig heavy chain. Statistical analysis ** P<0.01; ns, not statistically significant.
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lated on the activation loop, which is believed to be a sign
of an active enzyme. Conversely, this significant increase
in Lck and Fyn phosphorylation is not observed upon iAbs
stimulation. Hence, the data suggest that, in marked con-
trast to iAbs, sAbs stimulation enhances Lck and Fyn acti-
vation. We postulate that the enhanced activation of Lck
and Fyn may result in a stronger tyrosine phosphorylation
of downstream molecules (including negative regulators,
such as c-Cbl and Dok2), which might imbalance TCR-
mediated signaling, thus dampening T-cell activation.Sustained activation is regulated by positive feedback
loops
We next investigated whether positive feedback loops may
be triggered by iAbs, thus leading to sustained activation
of TCR-mediated signaling. In particular, we explored the
regulatory circuit involving Lck phosphorylation by
activated Erk [11]. This model is based on observations
showing that the Erk-mediated phosphorylation of Lck
on serine 59 alters Lck mobility and the ability of the
SH2 domain of Lck to bind phosphotyrosines [19-21].
Stefanova et al. further demonstrated that Erk-mediated
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interfering with SHP-1-mediated Lck inactivation [11].
According to this model, active Erk would feedback to
Lck to sustain signaling. To assess whether stimulation
with iAbs triggers this Erk-mediated positive feedback loop,
T cells were stimulated with iAbs and sAbs and the phos-
phorylation of Lck on S59 was detected by the appearance
of a new Lck band running at 59 kDa by Western blot
[11]. As shown in Figure 3A and B, stimulation of T cells
with iAbs clearly resulted in the formation of p59 Lck (up
to 50% of total Lck), whereas this shift in the molecular
weight of Lck was barely detectable upon sAbs treatment.
To demonstrate that the appearance of p59 Lck in-
deed depends on Erk-mediated phosphorylation, T cells
were stimulated with iAbs for 30 min in the presence or
absence of U0126 or MEK Inhibitor I, inhibitors of the
Erk activator MEK. This treatment has previously been
shown to abolish the conversion of Lck to the p59 form
[11]. In agreement with these observations, we also
found that treatment of iAbs-stimulated T cells with
U0126 or MEK Inhibitor I completely abolished both
Erk activation and the shift of Lck to the p59 form
(Figure 3C). We next tested whether the molecular shift
of Lck upon iAbs stimulation is indeed induced by
phosphorylation of S59. To assess this issue, we took ad-
vantage of Lck constructs carrying S to D and S to A
mutations at this position, which mimic constitutiveFigure 3 iAbs induce an Erk-mediated positive feedback loop. A) Puri
immobilized (iAbs) CD3xCD28 mAbs for the indicated time points. Lck exp
Bands corresponding to p56 or p59 Lck were quantified as described in Fig
(p56+p59) Lck shown as arbitrary units ± SEM of 5 independent experimen
CD3xCD28 mAbs for the indicated time periods in the presence or absenc
blotting using the Abs indicated. One representative immunoblot of 4 inde
with various constructs carrying different mutations (S42A, S42D, S59A, S59
stimulated with iAbs for 45 min. Samples were analyzed by Western blottin
independent experiments is shown.phosphorylation or prevent phosphorylation, respectively.
We used the following mutants S59D, S59A, S42D, S42A,
and S42A/S59A, which were expressed in the Lck-
deficient Jurkat T-cell line J.CaM1.6. As shown in
Figure 3D, mutations of S42 do not affect the mobility shift
of Lck either in unstimulated or iAbs stimulated cells.
Conversely, the S59D mutation results in a constitutive
shift to p59 Lck, thus indicating that phosphorylation on
this site plays a major role in the regulation of Lck mobil-
ity. Accordingly, the S59A substitution, which results in a
non-phosphorylatable mutant, prevents the generation of
the 59 kDa form of Lck upon iAbs stimulation (Figure 3D).
In summary, these data demonstrate that Erk-mediated
phosphorylation of Lck at S59 results in its retarded mobil-
ity on SDS-PAGE.
To check whether the inhibition of Erk-mediated Lck
phosphorylation also resulted in a reduction of its activ-
ity, we investigated phosphorylation levels of down-
stream signaling molecules that are substrates of Lck,
such as the tyrosine kinase ZAP70 and the adaptor pro-
tein LAT whose phosphorylation depends on ZAP70. T
cells were stimulated for 30 min with iAbs. Subse-
quently, Erk activity was blocked by the addition of the
MEK inhibitor U0126. The data presented in
(Figure 4A, B) show that the phosphorylation of both
ZAP70 and LAT is reduced upon MEK inhibition, thus
indicating that Erk-mediated Lck phosphorylation mayfied human T cells were treated with either soluble (sAbs) or
ression was detected in cell lysates by anti-Lck immunoblotting. B)
ure 2. Data represent the ratio of the levels of p56 and p59, and total
ts. C) Purified human T cells were treated with immobilized (iAbs)
e of MEK Inhibitor I or U0126. Samples were analyzed by Western
pendent experiments is shown. D) J.CaM1.6 cells were transfected
D, S42A/S59A). After transfection, cells were either left unstimulated or
g using the indicated Abs. One representative experiment of five
Figure 4 An Erk-Lck feedback loop regulates TCR-mediated signaling. A) Purified human T cells were treated with iAbs alone for 30 min
and then either DMSO or the MEK inhibitor U0126 was added and incubated for an additional 30 to 60 min. Samples were analyzed by Western
blotting using the indicated Abs. B) Bands in A) were quantified and the values were normalized as described. Graphs show the mean of the
phosphorylation levels of Erk1/2, ZAP70, and LAT or the level of p59 Lck as arbitrary units ± SEM of 4 independent experiments. C) Purified
human T cells were preincubated either in the presence of DMSO or the MEK inhibitor U0126 and subsequently stimulated with sAbs for the
indicated time points. Samples were analyzed by Western blotting using the indicated Abs. D) Bands in C) were quantified as described above
and the data from at least two independent experiments are shown.
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stimulated T cells with the MEK inhibitor reduced Erk
phosphorylation, as expected, but not ZAP70 or LAT
phosphorylation (Figure 4C, D).
Collectively, these data suggest that stimulation with
iAbs activates an Erk-mediated positive feedback loop
which is required for proper T-cell response and prolifera-
tion. Importantly, the regulatory circuit induced by iAbs
seems to mimic a previously described mechanism that is
induced in T cells upon physiological stimulation [11].Enhancement of Src kinases phosphorylation converts
sustained into transient signal
The data presented above suggest that sAbs and iAbs in-
duce qualitatively different signals and feedback regula-
tion which are translated into distinct cellular responses.
How the cell senses the quality of the signal is not yet
fully understood. Our data suggest that sAbs induce
stronger Src kinases activation and a stronger tyrosine
phosphorylation pattern compared to iAbs stimulation
(Figure 1). These observations may suggest that Src
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nal. To test the contribution of Lck, the major Src kinase
in T cells, in the regulation of signaling dynamics, we
suppressed its expression by RNAi in Jurkat T cells and
evaluated the effects on Erk activation. Figure 5A shows
that cells expressing low amount of Lck displayed pro-
longed Erk1/2 activation. These observations are in line
with previous studies showing that knockdown of Lck in
Jurkat and primary human T cells prolonged Erk phos-
phorylation and transcriptional activation [22,23].
We next decided to investigate whether strong phos-
phorylation of Lck and Fyn may convert a sustained into a
transient signal. To this aim, CD4+ primary human T cells
were stimulated with iAbs for a short time period and sub-
sequently CD4 was cross-linked using soluble anti-CD4
mAbs. It is known that CD4 crosslinking results in trans-
phosphorylation of Lck, thus strongly enhancing its activ-
ity. As presented in Figure 5B, CD4 crosslinking indeed
resulted in a strong induction of Lck phosphorylation
measured using an anti-pY416Src antibody. Most import-
antly, enhanced Lck phosphorylation paralleled with a sig-
nificant reduction in Erk phosphorylation (Figure 5B).
Accordingly, we found that also CD69 expression and pro-
liferation were strongly reduced upon CD4 crosslinking
(Figure 5C, D). These data suggest that strong Src-family
kinase activity may result in the activation of inhibitory
signals suppressing T-cell activation.Figure 5 Lck phosphorylation correlates with decreased T-cell activat
control (Ctrl) and cultured for 48 h. Subsequently, cells were stimulated wit
were analyzed by immunoblotting using the indicated Abs. Immunoblot v
of three independent experiments is shown. B)-D) Purified human CD4+ T
presence or absence of cross-linked CD4 mAb as indicated. B) The phosph
blotting. The phospho-specific bands were quantified using the 1D ImageQ
β-actin signal. Data on the graph represent the mean of the phosphorylati
experiments. C) 24h after stimulation, the activation of CD4+ T cells was an
represent the mean of the expression levels shown as arbitrary units ± SEM
CFSE and stimulated as indicated. Proliferation was assed after 72h by anal
3 independent experiments is shown.In summary, we have shown that stimulation with
iAbs induces different feedback regulation than sAbs
treatment (Figure 6). sAbs lead to strong and rapid acti-
vation of Src kinases and subsequently to the phosphor-
ylation of inhibitory molecules (e.g. c-Cbl, Dok2), which
terminate signaling. On the other hand, iAbs induce only
slight increase in kinase activity and an Erk-Lck positive
feedback loop, which may be required to prevent rapid
Lck dephosphorylation by SHP-1 or other phosphatases,
and therefore lead to sustained activation.
Discussion
Signaling through a variety of plasma membrane-
associated receptors leads to cell decision processes such
as cell proliferation, differentiation, survival, and motil-
ity. Considerable evidence suggests that the magnitude
and the duration of a signal determine the functional
outcome. As little is known on the mechanisms regulat-
ing signaling kinetics correlating with cellular responses
in T cells, we have analyzed TCR-mediated signaling
under conditions leading to either T-cell unresponsive-
ness or to proliferation. We employed sAbs and iAbs
stimulation which induce qualitatively different signals
and T-cell responses [8]. We found striking differences
in TCR signaling kinetics and feedback regulation. In-
deed, under proliferation-inducing conditions, TCR-
mediated signaling is prolonged by a positive feedbackion. A) Jurkat T cells were transfected with Lck siRNA duplex or siRNA
h soluble CD3 mAbs (clone OKT3) for the indicated times. Cell lysates
erifying Lck downregulation is shown. One representative experiment
cells were treated with immobilized (iAbs) CD3xCD28 mAbs in the
orylation levels of Erk1/2 and Src kinases were determined by Western
uant software and the values were normalized to the corresponding
on levels shown as arbitrary units ± SEM of 3 independent
alyzed by staining with CD69 and flow cytometry. Data on the graph
of 3 independent experiments. D) CD4+ T cells were labeled with
yzing CFSE content on a LSRFortessa. One representative experiment of
Figure 6 Feedback regulation of TCR-mediated signaling. sAbs stimulation triggers strong phosphorylation of Src kinases, such as Lck, and
leads to strong activation of downstream signaling pathways. In addition to the activation of positive regulators, sAbs also induce inhibitory
molecules (c-Cbl, Dok2), which might imbalance TCR-mediated signaling, thus rapidly terminating T-cell activation (left side). On the other hand,
iAbs stimulation results in the activation of an Erk-Lck positive feedback loop, which is required to sustain signaling (right side).
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sAbs strongly activates inhibitory molecules that likely
terminate signaling. These observations are in agreement
with the model proposed by Acuto et al., that the signal
amplitude and kinetics in double positive thymocytes de-
pend on the type of the applied stimulus [13]. Here, we
show that a similar principle may apply also to mature T
cells.
An important question that needs further investiga-
tions is how signals with a common origin at the TCR
are split to activate different effector molecules. During
thymocyte development, it has been proposed that a
molecule or complex functioning as “signal splitter”
senses the intensity of signals emanating from the TCR
and discriminates between negatively and positively
selecting ligands [24]. However, such a molecule has not
yet been identified in immature T cells. We propose that
Lck may function as “signal splitter” in mature T cells
directing signals emanating from the TCR toward unre-
sponsiveness if the signal is at high intensity (i.e. in case
of stimulation with sAbs, which induce strong Src kinase
activation). This safety mechanism could be set in mo-
tion in case of an inappropriate stimulation that could
lead to T-cell hyperactivation and the development of
autoimmunity. The idea that the molecular switch is
located at the apical part of the cascade could represent
an advantage of the system. In fact, the termination of
the signal at a membrane proximal level will require
only the activation of a limited number of downstream
inhibitory pathways to efficiently stop activation. In case
of an appropriate stimulus, such as iAbs, Lck activity is
not substantially increased over the basal level. Asproposed by Nika et al., the pool of constitutively active
Lck is sufficient to initiate the signaling cascade [25].
This weaker signal will in turn activate positive feedback
loops which enhance the strength and prolong the acti-
vation of more distal signaling cascades, thus culminat-
ing in proliferation.
How Lck senses the characteristic of the stimulus trig-
gering the TCR, which will in turn result in the gener-
ation of the appropriate cellular program, is not yet
known. However, when we compared sAbs vs. iAbs, we
found that Lck undergoes different phosphorylation
events. Whereas sAbs enhance phosphorylation of Lck
at Y394, which is believed to enhance its kinase activity,
iAbs induce phosphorylation of Lck at S59. We propose
that phosphorylation at Y394 induced by sAbs results in
a hyper-phosphorylation of downstream signaling mole-
cules that disturbs the equilibrium between positive and
negative regulators of TCR-mediated signaling, favoring
inhibitory signals (like c-Cbl) that shutdown T-cell acti-
vation. This hypothesis is also supported by our observa-
tions and previously published data showing that
suppression of Lck expression by RNAi strongly impaired
the activation of the inhibitory molecules SHP-1 and
c-Cbl and also prolonged downstream signaling (i.e. pErk,
NFAT/AP-1) induced by soluble CD3 stimulation [22,23].
Thus, strong Lck activation may have inhibitory effects on
T-cell activation. On the other hand, phosphorylation on
S59 may be required to prevent rapid deactivation by SHP-
1. Moreover, if Lck becomes strongly active, this would in
turn shutdown signaling as in the case of sAbs stimula-
tion. Interesting in this regard, we found that iAbs stimu-
lation not only enhances phosphorylation on S59 but
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time points after activation (Figure 2D and our unpub-
lished results).
We also found that crosslinking of CD4 in cells under-
going activation dampen T-cell responses. We propose
that a strong activation of Src kinases induced upon CD4
crosslinking may triggers inhibitory feedback loops in a
similar manner to sAbs. Interestingly, when anti-CD4 is
immobilized together with anti-CD3 on microbeads, T-cell
activation is enhanced compared to stimulation with anti-
CD3 alone. Under this condition, an enhanced Src kinase
phosphorylation was not observed [8]. Previous observa-
tions had shown that crosslinking of CD4 before stimula-
tion also impaired T-cell activation [26]. This mechanism
has been implicated in T-cell depletion occurring during
HIV infection [27]. Our data suggest that crosslinking of
CD4 by gp120 and anti-gp120 antibodies may shutdown
T-cell activation also during immune responses in HIV-
infected patients, thus contributing to immunodeficiency.
In addition to Lck, we have found major differences in
the regulation of Erk activation between sAbs and iAbs. It
has been previously shown that Erk activity in cytotoxic
mouse T lymphocytes after stimulation with immobilized
antibodies depends on nPKCs, whereas, sAbs stimulation
activates Erk also via cPKCs [28]. Thus, TCR-mediated
Erk activation under condition of stimulation correlating
with proliferation appears to be not only quantitatively,
but also qualitatively different from that induced by sAbs.
Conclusions
In summary, we show that TCR-mediated signaling kinetics
and feedback regulation under proliferation-inducing con-
ditions (iAbs) are markedly different from those leading to
unresponsiveness (sAbs) and we provide some potential
mechanistic insights that may explain this differential be-
havior. We hope that the comparative analyses presented
here will inspire further studies aimed at dissecting the
spatio-temporal regulation of T-cell activation.
Methods
Human Ethics
Approval for these studies involving the analysis of
TCR-mediated signaling in human T cells was obtained
from the Ethics Committee of the Medical Faculty at the
Otto-von-Guericke University, Magdeburg, Germany
with the permission number [107/09]. Informed consent
was obtained in writing in accordance with the Declar-
ation of Helsinki.
Cell purification
Peripheral blood mononuclear cells were isolated by Ficoll
gradient (Biochrom) centrifugation of heparinized blood
collected from healthy volunteers. Total population of
human T cells or CD4+ subpopulation were further purifiedby non-T cell depletion using T cell isolation kits (Miltenyi
Biotec). The purity of T cells, determined by flow cytome-
try, was usually more than 96%.T-cell stimulation
After isolation, T cells were cultured overnight in RPMI
1640 medium containing 10% FCS (PAN Biotech) and 2
μg/ml Ciprobay (Bayer Schering Pharma). Successively, T
cells were stimulated with either soluble or immobilized
mAbs as follows. For soluble Ab stimulation, 2x106 cells
were loaded with 10 μg/ml biotinylated anti-human CD3
(clone UCHT1, eBioscience) in combination with 10 μg/ml
biotinylated anti-human CD28 (clone CD28.2, eBioscience)
mAbs in 100 μl RPMI 1640 for 15 min on ice. After
washing, receptors were cross-linked by adding 25 μg/ml
NeutrAvidin™ (Pierce). For microbead stimulation,
SuperAvidin™-coated polystyrene microspheres (Ø~10
μm, Bangs Laboratories) were coated with biotinylated
CD3 in combination with CD28 mAbs (10 μg/ml each) for
30 min at 37°C in PBS. Antibody-coated microbeads were
washed twice with PBS, resuspended in RPMI 1640 and
incubated with T cells in a 1:1 ratio. For stimulation of pre-
activated cells 10 μg/ml of purified IgM anti-human CD4
(clone MEM16, kindly provided by V. Horejsi, Academy of
Sciences of the Czech Republic, Czech Republic) was used.
For Jurkat T cell stimulation soluble CD3 mAbs (clone
OKT3) was used.
Stimulations in the presence of either the MEK inhibi-
tor I, U0126 (Cell Signaling Technology) or DMSO
(Sigma-Aldrich) were performed by pre-incubating
T-cells for 30 min with 10 μM of the compounds before
stimulation with mAbs. For indicated microbead stimu-
lation, 10 μM of either UO126 or DMSO were added 30
min after stimulation.
Cell transfections
The Jurkat T-cell line and Lck-deficient variant of the
Jurkats (J.CaM1.6) were maintained in RPMI 1640
medium supplemented with 10% FCS (PAN Biotech) and
antibiotics at 37°C and 5% CO2. For cell transfection, we
used pBos expression plasmid encoding various Lck
constructs (S42A, S42D, S59A, S59D, S42A/S59A). For
RNAi experiments siRNA Lck duplex containing 21
nucleodites was purchased from Life Technologies. The
sequences were as follows, sense: 5’–UAACCAGGUU
GUCUUGCAGUG–3 antisense: 5’–CUGCAAGACAAC
CUGGUUAUC–3’. As a negative control we used a
Renilla Luciferase siRNA duplex 5´–CCAAGUAAU
GUAGGAUCAATT–3’. To achieve efficient transfection,
Jurkat T cells were electroporated using the Gene Pulser II
(Bio-Rad) as previously described [29]. 48 h after electro-
poration cells were collected, stimulated with iAbs or sAbs
as indicated, and processed for Western blotting.
Poltorak et al. Cell Communication and Signaling 2013, 11:4 Page 10 of 11
http://www.biosignaling.com/content/11/1/4Immunoprecipitation
Primary human T cells (3×107) were either left untreated
or stimulated with sAbs or iAbs for the indicated periods
of time. Cells were lysed in 1% Brj58 or 1% lauryl malto-
side (N-dodecyl β-maltoside), 1% IGEPAL CA-630, 1 mM
Na3VO4, 1 mM PMSF, 10 mM NaF, 10 mM EDTA,
50 mM Tris pH 7.5, and 150 mM NaCl, and cleared by
centrifugation. TCRζ chains were immunoprecipitated
with agarose-conjugated CD3ζ (Santa Cruz Biotechnology)
antibody followed by recombinant protein A-agarose
beads (Santa Cruz Biotechnology) at 4°C overnight. After
washing, TCRζ immunoprecipitates were resolved by
SDS-PAGE, transferred to a nitrocellulose membrane
(Amersham), and analyzed by immunoblotting with the
indicated antibodies.
Western blotting
T cells were lysed in buffer containing 1% lauryl malto-
side (N-dodecyl β-maltoside), 1% IGEPAL CA-630, 1
mM Na3VO4, 1 mM PMSF, 10 mM NaF, 10 mM EDTA,
50 mM Tris pH 7.5, and 150 mM NaCl. Post-nuclear
lysates were separated by SDS-PAGE and transferred
onto nitrocellulose membranes (Amersham). Mem-
branes were probed with the indicated primary anti-
bodies and the appropriate HRP-conjugated secondary
antibodies (Dianova) and developed using the ECL detec-
tion system (Amersham). The following antibodies were
used for Western blotting in this study: anti-phospho(p)-
T202/Y204 Erk1/2, anti-pY319ZAP70, anti-pY171LAT, anti-
pY783PLCγ1, anti-pS338-c-Raf, anti-pS217/221MEK1/2,
anti-pS380p90RSK, anti-pY731-c-Cbl, anti-pY351-p56Dok2,
anti-pY416Src (all from Cell Signaling Technology), anti-
Lck (from BD Transduction laboratories), anti-Lck (from
Epitomics), anti-Fyn (Fyn01, kindly provided by Vaclav
Horejsi), anti-ZAP70, anti-CD3ζ (Santa Cruz Biotechnol-
ogy), anti-pTyr (clone 4G10)-HRP conjugate (Millipore),
and anti-β-actin (clone AC-15) (Sigma-Aldrich). For
quantifications of the Western blots, the intensity of the
detected bands was acquired using the Epson Perfection
V700 Photo Scanner and analysis was performed using 1D
ImageQuant software (Kodak). Unless indicated other-
wise, β-actin was used as a loading control (typical loading
error in the experiment: ± 13%).
In vitro assays
Proliferation experiments were carried out in 96-well
plates (Costar). Purified human T cells or CD4+ subpo-
pulation were labeled with 2.5 μM CFSE (Molecular
Probes) for 10 min at 37°C. After washing, 2×105 cells
were seeded in a total volume of 200 μl to each well and
cultured in RPMI (supplemented with 10% FCS and
antibiotics). T cells were either left unstimulated or sti-
mulated with soluble or immobilized CD3×CD28 mAbs
in the presence or absence of soluble CD4 as indicated.T cells were cultured for 72 h at 37°C, 5% CO2. Prolif-
eration was assessed by CFSE dilution using a BD
LSRFortessa, FACSDiva Software 6.1.3 (BD Biosciences),
and FlowJo 7.6.5 (Tree Star, Inc.).
To determine the efficiency of T-cell activation, T cells
were stimulated as described above. After 24h, T cells
were stained with PE-labeled mAbs against CD69 (BD
Biosciences) and analyzed by flow cytometry.
TCR internalization
To determine TCR internalization, 1×106 cells were sti-
mulated with sAbs or iAbs as mentioned above at 37°C
for 0–60 min. Cells were stained with PE-conjugated
TCRαβ mAb (BD Biosciences) for 15 min at 4°C and
analyzed by flow cytometry.
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